This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Global Collagen And HA-Based Biomaterials Industry

Table 12: World 15-Year Perspective for Collagen-basedBiomaterials by Product Segment - Percentage Breakdown ofDollar Sales for Urinary Incontinence Products, CornealShields, Facial Aesthetic Dermal Fillers, and WoundDressings Markets for Years 2004, 2012 & 2018 (includescorresponding Graph/Chart) II-56

Table 13: World Recent Past, Current & Future Analysis forCollagen-based Urinary Incontinence Products by GeographicRegion - US, Canada, Japan, Europe and Rest of WorldMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) II-57

Table 14: World Historic Review for Collagen-based UrinaryIncontinence Products by Geographic Region - US, Canada, Japan, Europe and Rest of World Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2004 through 2009 (includes corresponding Graph/Chart) II-58

Table 15: World 15-Year Perspective for Collagen-basedUrinary Incontinence Products by Geographic Region -Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe and Rest of World Markets for Years 2004, 2012 &2018 (includes corresponding Graph/Chart) II-59

Table 16: World Recent Past, Current & Future Analysis forCollagen-based Corneal Shields by Geographic Region - US, Canada, Japan, Europe and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2010 through 2018 (includes correspondingGraph/Chart) II-60

Table 17: World Historic Review for Collagen-based CornealShields by Geographic Region - US, Canada, Japan, Europeand Rest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2004 through2009 (includes corresponding Graph/Chart) II-61

Table 18: World 15-Year Perspective for Collagen-basedCorneal Shields by Geographic Region - Percentage Breakdownof Dollar Sales for US, Canada, Japan, Europe and Rest ofWorld Markets for Years 2004, 2012 & 2018 (includescorresponding Graph/Chart) II-62

Table 19: World Recent Past, Current & Future Analysis forCollagen-based Facial Aesthetic Dermal Fillers byGeographic Region - US, Canada, Japan, Europe, and Rest ofWorld Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2010 through 2018(includes corresponding Graph/Chart) II-63

Table 20: World Historic Review for Collagen-based FacialAesthetic Dermal Fillers by Geographic Region - US, Canada, Japan, Europe and Rest of World Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2004 through 2009 (includes corresponding Graph/Chart) II-64

Table 21: World 15-Year Perspective for Collagen-basedFacial Aesthetic Dermal Fillers by Geographic Region -Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe and Rest of World Markets for Years 2004, 2012 &2018 (includes corresponding Graph/Chart) II-65

Table 22: World Recent Past, Current & Future Analysis forCollagen-based Wound Dressings by Geographic Region - US, Canada, Japan, Europe and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2010 through 2018 (includes correspondingGraph/Chart) II-66

Table 23: World Historic Review for Collagen-based WoundDressings by Geographic Region - US, Canada, Japan, Europe and Rest of World Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2004through 2009 (includes corresponding Graph/Chart) II-67

Table 24: World 15-Year Perspective for Collagen-basedWound Dressings by Geographic Region - Percentage Breakdownof Dollar Sales for US, Canada, Japan, Europe and Rest ofWorld Markets for Years 2004, 2012 & 2018 (includescorresponding Graph/Chart) II-68Hyaluronic Acid Based Biomaterials Market by GeographicRegion II-69Table 25: World Recent Past, Current & Future Analysis forHyaluronic Acid Based Biomaterials by Geographic Region -US, Canada, Japan, Europe and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2010 through 2018 (includes correspondingGraph/Chart) II-69

Table 26: World Historic Review for Hyaluronic Acid BasedBiomaterials by Geographic Region - US, Canada, Japan, Europe and Rest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2004 through2009 (includes corresponding Graph/Chart) II-70

Table 27: World 15-Year Perspective for Hyaluronic AcidBased Biomaterials by Geographic Region - PercentageBreakdown of Dollar Sales for US, Canada, Japan, Europe andRest of World Markets for Years 2004, 2012 & 2018 (includescorresponding Graph/Chart) II-71Hyaluronic Acid Based Biomaterials Market by Product Segment II-72Table 28: World Recent Past, Current & Future Analysis forHyaluronic Acid Based Biomaterials by Product Segment -Viscosupplements, Viscoelastics and Facial Aesthetic DermalFillers Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) II-72

Table 29: World Historic Review for Hyaluronic Acid BasedBiomaterials by Product Segment - Viscosupplements,Viscoelastics and Facial Aesthetic Dermal FillersIndependently Analyzed with Annual Sales Figures in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) II-73

4 of 12

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,172.68 -107.06 -0.62%
S&P 500 1,994.29 -16.11 -0.80%
NASDAQ 4,527.6890 -52.10 -1.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs